71173-3000 NDC - BUDDATE REGES INTENSIVE TREATMENT (BUTYLENE GLYCOL, HYDROGENATED COCONUT OIL, BUTYROSPERMUM PARKII (SHEA) BUTTER, PALMITOYL TRIPEPTIDE-1, PALMITOYL TETRAPEPTIDE-7)

Drug Information

Product NDC: 71173-3000

Proprietary Name: BUDDATE REGES INTENSIVE TREATMENT

Non Proprietary Name: Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7

Active Ingredient(s):
  • 5.57 g/100mL BUTYLENE GLYCOL;
  • 4 g/100mL HYDROGENATED COCONUT OIL;
  • .000006 g/100mL PALMITOYL TETRAPEPTIDE-7;
  • .000006 g/100mL PALMITOYL TRIPEPTIDE-1;
  • 3 g/100mL SHEA BUTTER


Administration Route(s): TOPICAL

Dosage Form(s): CREAM

Labeler Information

Labeler Name: BUDDATE Co Ltd
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:1/1/2017

Package Information

No. Package Code Package Description Billing Unit
171173-3000-170 mL in 1 TUBE (71173-3000-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC71173-3000The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBUDDATE REGES INTENSIVE TREATMENTThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEButylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECREAMThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/1/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBUDDATE Co LtdName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBUTYLENE GLYCOL; HYDROGENATED COCONUT OIL; PALMITOYL TETRAPEPTIDE-7; PALMITOYL TRIPEPTIDE-1; SHEA BUTTERAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH5.57; 4; .000006; .000006; 3 
ACTIVE INGRED UNITg/100mL; g/100mL; g/100mL; g/100mL; g/100mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023